Popular Trials
Bacterial Extract
Oral Bacterial Extract for Wheezing
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial tests if giving Broncho-Vaxom® to high-risk infants can delay their first episode of wheezing illness. The medication is given regularly over a long period and aims to boost the immune system. The study focuses on infants aged 6-18 months who are more likely to develop asthma.
Lipid Mediator
Anti-Inflammatory Lipid Mediator for Asthma
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial tests CXA-10, a synthetic compound that reduces inflammation, in obese adults with asthma. The goal is to see if it can help control asthma symptoms by calming down the body's immune response.
Popular Filters
Trials for Allergy And Asthma Patients
Behavioural Intervention
Compression Stockings for Asthma
Recruiting1 award1 criteria
Toronto, Ontario
"This trial aims to study the effectiveness of wearing compression stockings below the knee in reducing fluid shift and airway narrowing during the night in asthma patients. Nocturnal asthma symptoms are common and can be wors
EVH + Mannitol for Cough Variant Asthma
Recruiting3 awardsPhase 4
Kingston, Ontario
This trial will help determine if Eucapneic Voluntary Hyperventilation (EVH) and Hypertonic Saline (HS) can help individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH).
Trials for Childhood Asthma Patients
Behavioral Intervention
Hospital to Home Transition for Childhood Asthma
Recruiting1 award2 criteria
Washington DC, District of Columbia
This trial will recruit caregiver-child pairs during a child's hospital admission for asthma. Participants will be recruited from Children's National Hospital Sheikh Zayed campus, Holy Cross Hospital, and Mary Washington Hospital. After
Behavioural Intervention
AeviceMD for Pediatric Asthma
Recruiting1 award
Los Angeles, California
This trial aims to use a wearable device called AeviceMD to monitor the breathing of pediatric asthma patients at home. By using this device, patients can better manage their asthma, and doctors can adjust treatments
Electrolyte Supplement
Early Magnesium Sulfate for Childhood Asthma
Recruiting0 awardsPhase < 1
Oklahoma City, Oklahoma
This trial is trying to find out if giving magnesium sulfate early to children with moderate asthma attacks can help prevent them from being admitted to the hospital, reduce the time they spend in the emergency room and hospital
Phase 3 Trials
Monoclonal Antibodies
Depemokimab for Asthma
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial is testing a new medication called Depemokimab for people with severe asthma who have high levels of certain white blood cells. The goal is to see if switching to Depemokimab works as well as their current treatments. The medication aims to reduce these white blood cells to help control asthma symptoms.
Monoclonal Antibodies
Depemokimab for Severe Asthma
Recruiting2 awardsPhase 3
Dallas, Texas
This trial is testing Depemokimab, a medication for people with severe asthma that doesn't respond well to usual treatments. It works by reducing specific cells that cause airway inflammation, aiming to improve breathing and reduce symptoms.
Benralizumab for Asthma
Recruiting1 awardPhase 3
Mobile, Alabama
This trial tests benralizumab, an injectable medication, in children and teenagers aged 6 to 18 with severe eosinophilic asthma. The medication works by reducing specific white blood cells that cause lung inflammation, helping to control asthma symptoms. Benralizumab helps improve lung function for patients with severe, uncontrolled asthma with eosinophilic inflammation.
Corticosteroid
Fluticasone + Albuterol for Asthma
Recruiting2 awardsPhase 3
Pittsburg, Texas
This trial tests different doses of a combination of fluticasone and albuterol in an electronic inhaler for asthma patients. The goal is to reduce severe asthma attacks by decreasing lung inflammation and opening airways. Fluticasone is a potent anti-inflammatory medication, and albuterol helps to open airways.
Trials With No Placebo
Behavioural Intervention
Compression Stockings for Asthma
Recruiting1 award1 criteria
Toronto, Ontario
"This trial aims to study the effectiveness of wearing compression stockings below the knee in reducing fluid shift and airway narrowing during the night in asthma patients. Nocturnal asthma symptoms are common and can be wors
EVH + Mannitol for Cough Variant Asthma
Recruiting3 awardsPhase 4
Kingston, Ontario
This trial will help determine if Eucapneic Voluntary Hyperventilation (EVH) and Hypertonic Saline (HS) can help individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH).
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.